Lumexa Imaging Holdings, Inc. Common Stock

Fundamentals0.0
Price Action4.0
News Sentiment6.0
AI Rating
5.0

Key Drivers

  • Mild bearish trend
  • Support holding
  • Reclaim $11.70

AI
AI Summary

5.0

LMRI is a leveraged execution investment—not a headline-driven value play—where upside depends on converting 6%–7% same-site growth and advanced-imaging expansion into free cash flow that reduces its ~3.5x leverage; investors should wait for evidence that de novo expansion strengthens EBITDA without consuming cash or prolonging deleveraging.

GrowthPotential
LeverageRisk
Execution‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

0.0

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Mild bearish trend
  • •Support holding
  • •Reclaim $11.70

LMRI is mildly bearish over the last month, with $11.18 support critical and a sustained move above $11.70 needed to improve momentum.

Bearish
Watchlist
Support Level: $11.18
Resistance Level: $11.85–$12.19

Sharp decline from $12.19 to $11.18 in six days

Sentiment & News

6.0

Key News Insights:

  • •BlackRock Position
  • •Analyst Upgrade
  • •Investor Outreach

Lumexa gained institutional backing and bullish analyst sentiment, signaling improved investor interest despite no new operating results.

InstitutionalBuying
BullishOutlook

The developments may support positive near-term sentiment for LMRI, though fundamental execution remains the key catalyst